Domo Experts From Citrus Ad and DHL to Present at the Forrester Data Strategy & Insights Virtual Trade Show

Data and Technology Leaders will Share How They Are Leveraging Data and Domo to Solve Today’s Complex Business Challenges

Domo (Nasdaq: DOMO), provider of the Domo Business Cloud, today announced that two customers – Citrus Ad and DHL – will be hosting separate sessions at the Forrester Data Strategy & Insights Virtual Trade Show to share how they are leveraging data and Domo to solve today’s complex business challenges. The event is being held from October 13 – 15 and Domo is a premium sponsor.

“Domo empowers organizations of all sizes to unlock the value of their business data. Join our customer sessions led by data and technology leaders at Citrus Ad and DHL, as they share how Domo has empowered them to help their organizations be more agile, and create a data-driven culture through well-governed, self-service BI and analytics,” said John Mellor, chief strategy officer, Domo.

Details on the

Read More
Read More

Tyme Technologies to Present at Jefferies Virtual Global Healthcare Conference on November 17-19, 2020

Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that its leadership will present at the Jefferies Virtual Global Healthcare Conference on November 17-19. In one-on-one sessions, the Company will present its corporate overview for fiscal year 2021 with a special focus on multiple growth opportunities driven by advances in the science of cancer cell metabolism, SM-88 (racemetyrosine) late-stage trials in pancreatic cancer, SM-88 HopES trial in ultra-rare metastatic sarcoma, proof-of-concept RESPOnD™ trial evaluating TYME-19 in COVID-19, and expanding clinical plans for its cancer-metabolism pipeline candidate SM-88 in prostate, breast and hematological cancers.

Event: Jefferies Virtual Global Healthcare Conference
Place: Waldorf Hilton, London
Presentation Date: November 17-19, 2020
Format: One-on-one sessions

The presentation will be accessible on the events page under the investor relations section of Tyme Technologies’ website at www.tymeinc.com.

About SM-88

SM-88 is an oral investigational modified proprietary tyrosine derivative that

Read More
Read More

Chemical Segment to Present Lucrative Opportunities in Air Separation Plants Market, China to Exhibit Promising Growth

Owing to the increased adoption of air separation plants in chemical, healthcare and food industry, revenue is set to steer up tremendously through 2029.

DUBAI, UAE / ACCESSWIRE / October 12, 2020 / The air separation plant market expected to surpass US$ 4870.6 million by 2029 as a part of which China and India is expected to witness a positive graph for the demand and production of air separation plants market. Due to increasing demand in major industries, manufacturers are working on developing on-site customized plant systems to gain a steady growth.

“Among the others, though chemical industry will hold maximum share, it will not outsell other major industries. It will surely dominate the market and will hold a considerable share but customized side of it will help the profit rise tremendously. Manufacturers are also focussing on better utilization of resources, raw materials and decreasing labour cost to enhance revenue

Read More
Read More

Researchers apply CRISPR technology to eliminate fusion genes present in tumor cells

The CRISPR/Cas9 gene-editing tool is one of the most promising approaches to advancing treatments of genetic diseases – including cancer -, an area of research where progress is constantly being made.

Now, the Molecular Cytogenetics Unit led by Sandra Rodríguez-Perales at the Spanish National Cancer Research Centre (CNIO) has taken a step forward by effectively applying this technology to eliminate so-called fusion genes, which in the future could open the door to the development of cancer therapies that specifically destroy tumors without affecting healthy cells. The paper is published in Nature Communications.

Fusion genes are the abnormal result of an incorrect joining of DNA fragments that come from two different genes, an event that occurs by accident during the process of cell division. If the cell cannot benefit from this error, it will die and the fusion genes will be eliminated.

Read More
Read More

How the Humboldt squid’s genetic past and present can secure its future — ScienceDaily

A group of marine biologists is pushing for more international collaboration to manage the Humboldt squid population after their study to identify its genetic stocks revealed its vulnerability to overfishing by fleets trying to feed the world’s hunger for squids.

Hiroshima University marine biologist Gustavo Sanchez led a team of researchers to find out the genetic structure of the Humboldt squid population in the Eastern Pacific Ocean using two types of DNA markers — the mitochondrial ND2 gene and nuclear microsatellite loci.

The team found that Humboldt squids could trace back their population to three historical matrilineage that spread out during the late Pleistocene and that the species has at least two contemporary genetic stocks homogeneously co-distributed in the northern and southern hemispheres.

Different genetic stocks within a species are usually defined by where they feed and breed. But in Humboldt squids, DNA markers showed no north-south divide. The equator

Read More
Read More

Insilico Medicine to present at Leveraging Intelligent Tech for Drug Development

IMAGE

IMAGE: Leveraging intelligent tech for drug development.
view more 

Credit: Insilico Medicine

Wednesday, September 30, 2020 – Insilico Medicine, a global leader in artificial intelligence for drug discovery and development, will present its latest results in modern and next-generation AI for drug discovery and productive longevity at the Live Leveraging Intelligent Tech for Drug Development Forum on September 30, 2020.

AI, automation and data integration are condensing the timeline from discovery to development and solving biological problems. On September 30th, leaders from biotech and pharma will discuss specific examples of how these technological advancements are reshaping the drug development landscape.

While technology continues to revolutionize biotech, pharmaceutical companies are investing heavily in modernizing internally to embrace and embed these innovations throughout their organizational structure and culture. On the clinical trial front, not only are sponsors pressed to have remote and decentralized designs for their trial models due to the ongoing

Read More
Read More

How the Humboldt squid’s genetic past and present can secure its future

How the Humboldt squid's genetic past and present can secure its future
A paralarva of the Humboldt squid. These cephalopods emerge from their eggs as one-millimeter paralarvae but grow to over 1.2 meters when they reach maturity. To sustain their growth within their one-year lifespan, these pack hunters go on a feeding frenzy, sometimes eating each other. Credit: Dr. Mitsuo Sakai

A group of marine biologists is pushing for more international collaboration to manage the Humboldt squid population after their study to identify its genetic stocks revealed its vulnerability to overfishing by fleets trying to feed the world’s hunger for squids.


Hiroshima University marine biologist Gustavo Sanchez led a team of researchers to find out the genetic structure of the Humboldt squid population in the Eastern Pacific Ocean using two types of DNA markers—the mitochondrial ND2 gene and nuclear microsatellite loci.

The team found that Humboldt squids could trace back their population to three historical matrilineage that spread out during the late

Read More
Read More

ATO wants to verify citizens are alive and physically present for myGovID registrations

mygovid.png

The Australian Taxation Office (ATO) is looking to introduce a “liveness” feature to myGovID, the Australian’s government’s digital identity credential.

The agency, which handles myGovID, has gone to market seeking a supplier to deliver a software solution that will allow people who are registering to prove they are a live person and physically present, as well as allow them to take a selfie to verify their identity against a stored identity document, such as their passport or driver’s licence.

The ATO quietly released the app last year to enable citizens to have their identity verified once so they could access government services online using their verified identity, rather than having to continually be verified by each Commonwealth entity.

The ATO emphasised that the successful contractor would need to adhere to strict security guidelines. These include delivering a security management and governance functionality in accordance with the Australian Cyber Security Centre

Read More
Read More

Exro to Present at the Virtual Gravitas Clean Technology Investor Day

Exro is pleased to announce it will be participating in the Gravitas Clean Technology Investor Day

CALGARY, AB / ACCESSWIRE / September 23, 2020 / Exro Technologies Inc. (the “Company” or “Exro”) (TSXV:EXRO)(OTCQB:EXROF), a leading technology company which has developed a new class of power electronics for powertrains, is pleased to announce it will be participating in the Gravitas Clean Technology Investor Day taking place Thursday, September 24th, 2020 virtually.

Exro’s Chief Executive Officer, Sue Ozdemir, is scheduled to present on Thursday, September 24th, 2020 at 10:45 AM PST. Ms. Ozdemir will also be fielding investor questions during the one-day virtual conference hosted by Gravitas Securities Inc. “I am looking forward to sharing our growth strategy with investors at the Gravitas Clean Technology Investor Day,” said Ms. Ozdemir. “With our proof of concept for the 100V Coil Driver to be delivered by Q4 2020, the Gravitas Clean Technology Investor Day

Read More
Read More